Effect of restoration of euthyroidism on visfatin concentrations and body composition in women.

Szczegóły
Abstrakt

Tytuł:: Effect of restoration of euthyroidism on visfatin concentrations and body composition in women.
Autorzy:: Sawicka-Gutaj N; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Zybek-Kocik A; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Kloska M; Lehigh Valley Health Network, Department of Medicine, Lehigh Valley Hospital - Cedar Crest, Allentown, USA.
Ziółkowska P; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Czarnywojtek A; Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland.
Sowiński J; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Mańkowska-Wierzbicka D; Department of Gastroenterology, Internal Medicine, Metabolic Diseases and Dietetics, Poznan University of Medical Sciences, Poznan, Poland.
Ruchała M; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Źródło:: Endocrine connections [Endocr Connect] 2021 Apr 26; Vol. 10 (4), pp. 462-470. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Bristol : BioScientifica
References:: J Endocrinol Invest. 2009 May;32(5):435-9. (PMID: 19498324)
Int J Cardiol. 2017 Mar 1;230:115-119. (PMID: 28038798)
Endocrine. 2016 Aug;53(2):497-504. (PMID: 26767650)
J Endocr Soc. 2019 May 16;3(7):1345-1356. (PMID: 31286098)
Ann Nutr Metab. 2015;66(2-3):63-71. (PMID: 25612646)
Clin Endocrinol (Oxf). 2009 Nov;71(5):733-8. (PMID: 19222486)
Horm Metab Res. 2018 Sep;50(9):653-660. (PMID: 30184561)
J Clin Endocrinol Metab. 2006 Nov;91(11):4650-6. (PMID: 16940450)
Diabetes. 2005 Oct;54(10):2911-6. (PMID: 16186392)
J Clin Endocrinol Metab. 2018 Aug 15;:. (PMID: 30124904)
Thyroid. 2006 Apr;16(4):375-80. (PMID: 16646684)
Chin Med J (Engl). 2012 Mar;125(5):874-81. (PMID: 22490590)
Biomed Res Int. 2018 Feb 6;2018:1316390. (PMID: 29546048)
Ther Adv Endocrinol Metab. 2017 Aug;8(8):119-125. (PMID: 28979761)
Clin Obes. 2019 Oct;9(5):e12328. (PMID: 31267667)
Eur Thyroid J. 2018 Aug;7(4):167-186. (PMID: 30283735)
Tumour Biol. 2015 Sep;36(10):7859-63. (PMID: 25946974)
Endocrinology. 2008 Apr;149(4):1543-50. (PMID: 18096661)
Clin Endocrinol (Oxf). 2016 Jun;84(6):799-808. (PMID: 26010808)
J Clin Endocrinol Metab. 2011 Jan;96(1):E99-103. (PMID: 20926526)
Int J Endocrinol. 2016;2016:7402469. (PMID: 26884761)
Best Pract Res Clin Endocrinol Metab. 2018 Apr;32(2):155-164. (PMID: 29678283)
Endokrynol Pol. 2016;67(4):359-66. (PMID: 26884294)
Thyroid. 2016 Mar;26(3):347-55. (PMID: 26700485)
Metabolism. 2008 Oct;57(10):1380-3. (PMID: 18803942)
Horm Metab Res. 2015 Jul;47(8):577-80. (PMID: 25671800)
Thyroid. 2013 Apr;23(4):408-13. (PMID: 23253072)
Endokrynol Pol. 2020;71(1):21-26. (PMID: 31851370)
Diabetes Res Clin Pract. 2007 Apr;76(1):24-9. (PMID: 16956691)
Endokrynol Pol. 2019;70(6):504-510. (PMID: 31891413)
J Endocrinol Invest. 2002 Jul-Aug;25(7):620-3. (PMID: 12150337)
Thyroid. 2016 Oct;26(10):1422-1430. (PMID: 27465032)
Endokrynol Pol. 2020;71(2):109-115. (PMID: 32154570)
Diabetes Obes Metab. 2006 Mar;8(2):220-7. (PMID: 16448527)
Front Endocrinol (Lausanne). 2016 Apr 13;7:30. (PMID: 27148161)
Contributed Indexing:: Keywords: Graves’ disease; Hashimoto’s disease; fat tissue; nicotinamide phosphoribosyltransferase; pre-B-cell colony enhancing factor; visfatin
Entry Date(s):: Date Created: 20210325 Latest Revision: 20210514
Update Code:: 20240105
PubMed Central ID:: PMC8111308
DOI:: 10.1530/EC-21-0059
PMID:: 33764900
: Czasopismo naukowe

Full Text Finder

Dysregulation of thyroid function has known impact on body metabolism, however, data regarding metabolic outcome after restoration of thyroid function is limited. Therefore, the aim of the study was to investigate the effect of restoration of euthyroidism on serum visfatin, and its associations with insulin resistance and body composition. This is an observational study with consecutive enrollment. Forty-nine hyperthyroid (median age of 34 years) and 44 hypothyroid women (median age of 46 years) completed the study. Laboratory parameters and body composition analysis were assessed before and after the therapy. In the hyperthyroid group, visfatin concentrations increased (P < 0.0001), while glucose concentrations decreased (P < 0.0001). Total body mass and fat mass in the trunk and limbs significantly increased during the treatment. In the hypothyroid group, significant weight loss resulted from decrease of fat and muscle masses in trunk and limbs. Visfatin serum concentrations positively correlated with total fat mass (r = 0.19, P = 0.01) and insulin concentrations (r = 0.17, P = 0.018). In conclusion, restoration of thyroid function is not associated with beneficial changes in body composition, especially among hyperthyroid females.

Informacja